|
LOC145783 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
6.39799999646584E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62703184258817E-12 |
| Stage1-vs-Stage2 |
4.058600E-03 |
| Stage1-vs-Stage3 |
2.084600E-01 |
| Stage1-vs-Stage4 |
5.892800E-01 |
| Stage2-vs-Stage3 |
2.675100E-03 |
| Stage2-vs-Stage4 |
1.244070E-02 |
| Stage3-vs-Stage4 |
7.005000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.32360000004716E-06 |
| Normal-vs-Asian |
1.07099884516515E-11 |
| Caucasian-vs-AfricanAmerican |
2.607000E-01 |
| Caucasian-vs-Asian |
2.221200E-01 |
| AfricanAmerican-vs-Asian |
6.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.295600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62803104331033E-12 |
| Normal-vs-Age(81-100Yrs) |
2.12209999999047E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.073000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.458800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.723000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.756600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.067000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.052000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.74880000042488E-07 |
| Classical-VS-Follicular |
3.989800E-02 |
| Classical-VS-Other |
5.262000E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
6.10379999876898E-08 |
| Tall-VS-Other |
1.100810E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.605200E-01 |
| Follicular-VS-Normal |
1.32549526909997E-11 |
| Other-VS-Normal |
1.64205999999556E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.026280E-02 |
|
|
